|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Solubleurokinase plasminogen activator receptor measurements: influence of sample handling 显示文摘 | Riisbro R Christensen IJ Hcgdall C | 2001 | Int J Biol Markers2001，16，4： | 1 |
| 2 | Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases显示文摘 | Riisbro R Stephens RW Brenner N | 2001 | Gynecol Oncol2001，82，： | 1 |
| 3 | High serum YKL-40 levels in patients with primary breast cancer is related to short recurrence free survival显示文摘 | Johansen JS Christensen IJ Riisbro R | 2003 | Breast Cancer Res Treat2003，80，1： | 1 |
| 4 | High Serum YKL-40 Levels in Patients with Primary Breast Cancer is Related to Short Recurrence Free Survival显示文摘 | Julia S. Johansen Ib J. Christensen Rikke Riisbro Michael Greenall Chen Han Paul A. Price Kenneth Smith Nils Brünner Adrian L. Harris | 2003 | Breast Cancer Research and Treatment2003，，： | 1 |
| 5 | Monoclonal antibody TB-403:a fi rst-in-human,Phase I,double-blind,dose escalation study directed against placental growth factor in healthy male subjects显示文摘 | Martinsson-Niskanen T Riisbro R Larsson L | | 0，，： | 1 |
| 6 | Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases 显示文摘 | STEPHENS R W | 2001 | Gynecol Oncol2001，82，3： | 1 |
| 7 | High serum YKL-40 levels in patients with primary breast cancer is related to short recurrence free survival显示文摘 | Julia S.Johansen Ib J.Christensen Rikke Riisbro | | 0，，： | 1 |
| 8 | Elevated plasma levels of TIMP-1 correlate with plasma suPAR/uPA in patients with chronic myeloproliferative disorders显示文摘 | Jensen MK Holten-Andersen MN Riisbro R | 2003 | Eur J Haematol2003，71，5： | 1 |
| 9 | Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases显示文摘 | Riisbro R Stephens RW Brurnner N | 2001 | Gynecol Oncol2001，82，3： | 1 |
| 10 | Monoclonal antibody TB- 403 : a first-in-human, phase I, double-blind, dose escalation study directed against placental growth factor in healthy male subjects 显示文摘 | Martinsson-Niskanen T Riisbro R Larsson L | 2011 | Clinical Therapeutics2011，33，： | 1 |
| 11 | Monoclonal Antibody TB-403: A First-in-Human, Phase I, Double-Blind, Dose Escalation Study Directed Against Placental Growth Factor in Healthy Male Subjects 显示文摘 | Titti Martinsson-Niskanen Rikke Riisbro | 2011 | Clin Ther2011，33，9： | 1 |
| 12 | Monoclonal antibody TB-403:a first-in-human,Phase I,double-blind,dose escalation study directed against placental growth factor in healthy male subjects显示文摘 | Martinsson-Niskanen T Riisbro R Larsson L | 2011 | Clin Ther2011，33，： | 1 |
| 13 | Monoclonal antibody TB-403: a first-in-human, Phase I, double-blind, dose escalation study directed against placental growth factor in healthy male subjects显示文摘 | Martinsson-Niskanen T Riisbro R Larsson L | 2011 | Clin Ther2011，33，9： | 1 |
| 14 | High serum YKL-d0 lev- els in patiehts with primary breast cancer is related to short recurrence free survival 显示文摘 | Johansen JS Christensen I J Riisbro R | 2003 | Breast Cancer Res Treat2003，80，1： | 1 |
| 15 | High serum YKL 40 levels in patients with primary breast cancer is related to short recurrence free survival 显示文摘 | Johansen JS Christensen IJ Riisbro R | 2003 | Breast Cancer Res Treat2003，80，1： | 1 |
| 16 | Soluble uro-kinase plasminogen activator receptor in preoperatively obtained plasma from patients with gyneco logical cancer or benign gyneco logical diseases显示文摘 | RIISBRO R STEPHENS R W BRNNER N | 2001 | Gynecol Oncol2001，82，： | 1 |
| 17 | High Serum YKL-40 Levels in Patients with Primary Breast Cancer is related to Short Recurrence Free Survival显示文摘 | Johansen JS Christensen IJ Riisbro R | 2003 | Breast Cancer Res Treat2003，80，1： | 1 |
| 18 | Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases显示文摘 | Stephens RW Brunner N | 2001 | Gynecol Oncol2001，82，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员